Login

Mabel Ryder, M.D. Endocrinologist, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Ask Mayo Clinic: Thyroid Cancer

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Isaac Kohane, MD, PhD Chair of the Department of Biomedical Informatics, Harvard Medical School | Artificial Intelligence and NEJM AI
00:10:00
Cana Gold CEO Presentation at Metals Investors Forum.
00:10:00
Silver One: Revitalizing Historic Silver Mines and Exploring New Opportunities
00:10:00
Exclusive Interview with Ajax’s New General Manager: Alex Kroes | Alex Kroes, CEO, AFC Ajax N.V.
00:10:00
Virginie Morgon on Eurazeo's Strategic Growth and Global Impact | Virginie Morgon, CEO, Eurazeo.
00:10:00
Chris Lee on Job Growth from Ports America's Investment in the Port of Oakland
00:10:00
Backs very early-stage founders on both coasts often before they have a product in the market|Raanan Bar-Cohen,Co-Founder,Resolute Ventures
00:10:00
Mark Barrenechea, CEO of OpenText Corp., discusses his favorite city, restaurant, and travel experiences.
00:10:00
AJ Bell Reviews Lazard Emerging Markets Fund with Ryan Hughes
00:10:00
Cabral Gold: Advanced Gold Exploration in Brazil's Prolific Tapajós District
00:10:00
Success Stories Of Human-AI Collaboration|Benjamin Levy,Co-Founder and General Partner,BootstrapLabs
00:10:00
Machine Learning Revolutionizing Pricing in the Corporate Bond Market

© 2026 Nehu